The center will be co-financed by the Chengdu Municipal Government and will help the sustainable development of West-China’s manufacturing industry, urbanization and industrial economy. The new center will help to develop modern genome engineering, biotech drugs, high value fine chemicals, bio-based plastics, high-end health products, for the conversion of bio-industry core technology to the whole chain of industrial biotechnology products. As an operating entity, Chengdu Ketai Wo Biological Technology Ltd. ” will be headquartered in Chengdu’s Tianfu District at the Chengdu Science City construction site.”

CAS news release, August 19, 2016